Serum and Peritoneal Fluid Bank for Endometriosis Markers
Public ClinicalTrials.gov record NCT00194233. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Serum and Peritoneal Fluid Bank for Assessment of Markers of Endometriosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to investigate differences in protein expression profiles of blood and peritoneal fluid samples obtained from patients who do, and those who do not, have endometriosis seen during laparoscopic surgery. These profiles may include both known and novel markers for diagnosing endometriosis.
Study identification
- NCT ID
- NCT00194233
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2003
- Primary completion
- Dec 31, 2006
- Completion
- May 31, 2008
- Last update posted
- Aug 15, 2016
2003 – 2008
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Pennsylvania Reproductive Research Unit | Philadelphia | Pennsylvania | 19104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Endometriosis trials
Other public records listing Endometriosis. Sorted by last update posted; newest first. Not a recommendation.
- NCT07795125: Rimegepant For Endometriosis Pain Not yet recruiting
- NCT07728695: Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain Recruiting
- NCT05069740: Endometriosis and Microvascular Dysfunction: Role of Inflammation Recruiting
- NCT06477406: Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis Recruiting
- NCT06785129: Endometriosis and Migraine Recruiting
- NCT07679074: CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00194233, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 15, 2016 · Synced Sep 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00194233 live on ClinicalTrials.gov.